138 related articles for article (PubMed ID: 140398)
1. Interaction of perphenazine and an ergoline derivative on oestrogen-induced adenohypophyseal growth.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(1):31-8. PubMed ID: 140398
[TBL] [Abstract][Full Text] [Related]
2. Inhibition by an ergoline derivative (dopaminergic agonist) of oestradiol-induced adenohypophyseal growth and of the decrease in the hypothalamic ascorbic acid (HAA) concentration in rats.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1982; 31(2):97-100. PubMed ID: 6212960
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of the oestradiol-induced increase in adenohypophyseal weight and in hypothalamic and serum polyphenol oxidase activity by dopaminergic agonists.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1983; 32(2):117-20. PubMed ID: 6408657
[TBL] [Abstract][Full Text] [Related]
4. Reactions of hypothalamic ascorbic acid, serum ceruloplasmin and the adenohypophysis to oestradiol: inhibition by L-thyroxine.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1980; 29(1):11-20. PubMed ID: 6444734
[TBL] [Abstract][Full Text] [Related]
5. Dopaminergic antagonists potentiate the adenohypophyseal growth reaction to oestrogen: thioridazine is less effective than perphenazine.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1987; 36(1):9-13. PubMed ID: 2884683
[TBL] [Abstract][Full Text] [Related]
6. Dopaminergic modulation of the adenohypophyseal reaction to oestradiol: interaction of perphenazine with the thyroid hormones.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1980; 29(2):173-9. PubMed ID: 6446099
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of thyroxine binding to adenohypophysial proteins in vitro by 2,4-dinitrophenol administered in vivo.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1975; 24(2):147-56. PubMed ID: 124882
[TBL] [Abstract][Full Text] [Related]
8. Dopaminergic control of adenohypophyseal growth.
Schreiber V
Vopr Biokhim Mozga; 1978; 13():221-7. PubMed ID: 756643
[TBL] [Abstract][Full Text] [Related]
9. Nucleolar inhibition in prolactin cells after combined thyroid hormone plus lisuride treatment in estrogenized rats.
Dusková J; Schreiber V
Endocrinol Exp; 1989 Sep; 23(3):185-94. PubMed ID: 2572415
[TBL] [Abstract][Full Text] [Related]
10. Effect of interaction of oestrogen, testosterone and thyroid hormones on the serum ceruloplasmin level in rats.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; (2):129-37. PubMed ID: 140385
[TBL] [Abstract][Full Text] [Related]
11. Metoclopramide potentiates the hypophyseal reactions to oestradiol.
Schreiber V; Dusková J; Pribyl T; Svobodová V; Jahodová J
Physiol Bohemoslov; 1984; 33(5):385-9. PubMed ID: 6505072
[TBL] [Abstract][Full Text] [Related]
12. Antioestrogenic action of the aldosterone antagonist canrenoate K in the rat (adenohypophysis, ceruloplasmin).
Schreiber V; Pribyl T
Physiol Bohemoslov; 1977; 26(5):385-95. PubMed ID: 144921
[TBL] [Abstract][Full Text] [Related]
13. Partial inhibition of oestrogen-induced adenohypophyseal growth by silver nitrate.
Pribyl T; Jahodová J; Schreiber V
Horm Res; 1980; 12(5):296-303. PubMed ID: 7399401
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of the growth reaction of the rat adenohypophysis to oestrogen by an ergoline derivative.
Schreiber B; Pribýl T; Rohácová J
Physiol Bohemoslov; 1973; 22(1):11-7. PubMed ID: 4269742
[No Abstract] [Full Text] [Related]
15. Modulation oestradiol effects by silver nitrate: inhibition of the adenohypophyseal reaction, block of the ceruloplasmin increase and block of hypothalamic ascorbic acid depletion.
Schreiber V; Pribyl T; Jahodová J
Endokrinologie; 1980 Oct; 76(2):129-36. PubMed ID: 7449747
[TBL] [Abstract][Full Text] [Related]
16. The effect of hexose monophosphate shunt inhibitors on adenohypophyseal and ceruloplasmin reactions to oestrogen.
Schreiber V; Pribyl T
Physiol Bohemoslov; 1978; 27(4):301-7. PubMed ID: 151286
[TBL] [Abstract][Full Text] [Related]
17. Dopaminergic control of adenohypophyseal growth after oestrogens: negative results with L-DOPA, RO-4-4602, alpha-methyl-DOPA, apomorphine, haloperidol, pyridoxine and cyproheptadine.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1978; 27(4):308-12. PubMed ID: 151287
[TBL] [Abstract][Full Text] [Related]
18. Modulation of the effect of oestradiol on adenohypophyseal weight: ineffectiveness of nickel chloride, potentiation by cimetidine.
Schreiber V; Pribyl T; Svobodová V; Jahodová J
Physiol Bohemoslov; 1984; 33(1):11-6. PubMed ID: 6709725
[TBL] [Abstract][Full Text] [Related]
19. Prolactin binding to mammary gland, 7,12-dimethylbenz(a)-anthracene-induced mammary tumors, and liver in rats.
Smith RD; Hilf R; Senior AE
Cancer Res; 1976 Oct; 36(10):3726-31. PubMed ID: 821605
[TBL] [Abstract][Full Text] [Related]
20. Restitution of endocrine changes after discontinuing chronic oestradiol administration in rats.
Schreiber V; Pribyl T; Jahodová J
Physiol Bohemoslov; 1978; 27(6):505-13. PubMed ID: 152926
[No Abstract] [Full Text] [Related]
[Next] [New Search]
